AMRZ vs. NUKZ

Last updated Jun 4, 2026

AMRZ (Amrize Ltd) is a stock, while NUKZ (Range Nuclear Renaissance ETF) is Energy Equities fund tracking the Range Nuclear Renaissance Index. At a 0.36 correlation, their price movements are largely independent.

Performance

AMRZ vs. NUKZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amrize Ltd (AMRZ) and Range Nuclear Renaissance ETF (NUKZ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, AMRZ achieves a 0.56% return, which is significantly lower than NUKZ's 13.31% return.

AMRZ

• 1D: -0.92%
• 1M: 6.00%
• YTD: 0.56%
• 6M: 3.35%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

NUKZ

• 1D: -2.59%
• 1M: -0.90%
• YTD: 13.31%
• 6M: 10.66%
• 1Y: 41.42%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

AMRZ vs. NUKZ - Yearly Performance Comparison

	2026 (YTD)	2025
AMRZ Amrize Ltd	0.56%	4.02%
NUKZ Range Nuclear Renaissance ETF	13.31%	17.73%

Correlation

The correlation between AMRZ and NUKZ is 0.36, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Jun 24, 2025	0.36

Return for Risk

AMRZ vs. NUKZ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NUKZ

NUKZ Risk / Return Rank: 40
NUKZ Sharpe Ratio Rank: 38
NUKZ Sortino Ratio Rank: 38
NUKZ Omega Ratio Rank: 34
NUKZ Calmar Ratio Rank: 50
NUKZ Martin Ratio Rank: 39

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AMRZ vs. NUKZ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amrize Ltd (AMRZ) and Range Nuclear Renaissance ETF (NUKZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	AMRZ	NUKZ	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.40	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.14	1.75	-1.61

Drawdowns

AMRZ vs. NUKZ - Drawdown Comparison

The maximum AMRZ drawdown since its inception was -25.95%, smaller than the maximum NUKZ drawdown of -33.03%. Use the drawdown chart below to compare losses from any high point for AMRZ and NUKZ.

Drawdown Indicators

	AMRZ	NUKZ	Difference
Max Drawdown Largest peak-to-trough decline	-25.95%	-33.03%	+7.08%
Max Drawdown (1Y) Largest decline over 1 year	—	-16.51%	—
Current Drawdown Current decline from peak	-17.42%	-5.61%	-11.81%
Average Drawdown Average peak-to-trough decline	-8.69%	-6.01%	-2.68%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	6.55%	—

Volatility

Volatility by Period

	AMRZ	NUKZ	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	10.30%	—
Volatility (6M) Calculated over the trailing 6-month period	—	22.05%	—
Volatility (1Y) Calculated over the trailing 1-year period	35.09%	29.74%	+5.35%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	35.09%	32.70%	+2.39%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	35.09%	32.70%	+2.39%

Dividends

AMRZ vs. NUKZ - Dividend Comparison

AMRZ's dividend yield for the trailing twelve months is around 1.02%, more than NUKZ's 0.80% yield.

Position	TTM	2025	2024
AMRZ Amrize Ltd	1.02%	0.00%	0.00%
NUKZ Range Nuclear Renaissance ETF	0.80%	0.91%	0.09%

Frequently Asked Questions

Can I hold both AMRZ and NUKZ in my portfolio?

AMRZ and NUKZ have a correlation of 0.36, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.